EX-8 2 tm2410988d28_ex8.htm EXHIBIT 8

 

Exhibit 8

 

Joint Filing Agreement

 

PURSUANT TO RULE 13d-1(k)

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he, she or it knows that such information is inaccurate.

 

Date: June 21, 2024

 

Novartis BidCo Germany AG  
   
By: /s/ Jan-Hendrik Petersen  
  Name: Jan-Hendrik Petersen  
  Title: As Authorized Signatory  

 

Novartis BidCo AG    
     
By:

/s/ Daniel Weiss

 

/s/ Bertrand Bugnon

  Name: Daniel Weiss   Name: Bertrand Bugnon
  Title: As Authorized Signatory   Title: As Authorized Signatory
     
Novartis Pharma AG    
     
By:

/s/ Lukas Foertsch

 

/s/ Luca Hammel

  Name: Lukas Foertsch   Name: Luca Hammel
  Title: As Authorized Signatory   Title: As Authorized Signatory

 

Novartis AG    
     
By:

/s/ David Quartner

 

/s/ Tariq ElRafie

  Name: David Quartner    Name: Tariq ElRafie
  Title: As Attorney   Title: As Attorney